Remus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	128.8	72.3	47.2	30.38	11.49
Short-Term Investments	175.3	200.4	202.4	-	-
Cash & Short-Term Investments	304.1	272.7	249.6	30.38	11.49
Cash Growth	11.51%	9.25%	721.54%	164.51%	38.30%
Accounts Receivable	1,398	1,080	1,153	48.48	29.15
Receivables	1,495	1,290	1,335	48.48	29.15
Inventory	720.6	515.6	431.1	2.87	15.89
Prepaid Expenses	-	3.2	0.4	0.49	0.07
Other Current Assets	426.8	131.9	107.7	31.22	20.34
Total Current Assets	2,946	2,214	2,123	113.44	76.94
Property, Plant & Equipment	178	68.3	48.6	25.13	3.09
Long-Term Investments	2,570	1,953	1,064	206.16	30.68
Goodwill	87.3	87.3	87.3	-	-
Other Intangible Assets	2.4	2.6	2.1	0.5	-
Long-Term Deferred Tax Assets	-	-	-	1.27	0.41
Other Long-Term Assets	2.1	1.2	5.9	0.12	47.49
Total Assets	5,787	4,326	3,331	346.61	158.6
Accounts Payable	760.4	712.9	937.1	35.31	46.73
Accrued Expenses	-	14.6	10.4	8.61	2.75
Short-Term Debt	-	171.2	83.4	6.38	-
Current Portion of Long-Term Debt	173.7	3.6	2.1	2.16	0.93
Current Portion of Leases	10.1	5.1	5.1	-	-
Current Income Taxes Payable	66.1	28.1	14.4	6.75	4.71
Other Current Liabilities	480.7	279.8	358.6	22.41	36.71
Total Current Liabilities	1,491	1,215	1,411	81.62	91.84
Long-Term Debt	56.7	33.3	30	70.89	0.99
Long-Term Leases	30.2	16.6	21.7	-	-
Pension & Post-Retirement Benefits	-	5.7	4.2	2.75	-
Long-Term Deferred Tax Liabilities	325.1	229	111.6	-	-
Other Long-Term Liabilities	6.2	1	0.4	-	-
Total Liabilities	1,909	1,501	1,579	155.26	92.82
Common Stock	117.8	58.9	14.7	10.85	10
Additional Paid-In Capital	-	504.3	504.7	41.65	-
Retained Earnings	-	571.9	337.1	138.86	55.78
Comprehensive Income & Other	3,392	1,424	720.4	-	-
Total Common Equity	3,510	2,559	1,577	191.36	65.78
Minority Interest	367.4	266.9	175.2	-	-
Shareholders' Equity	3,877	2,826	1,752	191.36	65.78
Total Liabilities & Equity	5,787	4,326	3,331	346.61	158.6
Total Debt	270.7	229.8	142.3	79.43	1.92
Net Cash (Debt)	33.4	42.9	107.3	-49.05	9.57
Net Cash Growth	-22.14%	-60.02%	-	-	73.48%
Net Cash Per Share	3.54	3.64	9.50	-6.00	1.20
Filing Date Shares Outstanding	9.34	11.66	11.78	8.68	8.68
Total Common Shares Outstanding	9.34	11.66	11.78	8.68	8.68
Working Capital	1,455	998.4	712.2	31.82	-14.9
Book Value Per Share	375.66	219.47	133.82	22.05	7.58
Tangible Book Value	3,420	2,469	1,488	190.85	65.78
Tangible Book Value Per Share	366.06	211.76	126.23	21.99	7.58
Buildings	-	3.3	3.3	3.28	-
Machinery	-	69.7	35.8	31.07	7.89
Construction In Progress	-	-	0.1	0.22	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.